X-ZELL Next-Generation Cytology (NGC) platform now IVDR-compliant and FDA-listed
/
DateMar 21 2024
Medical technology company achieves direct market access SINGAPORE, March 21, 2024 /EINPresswire.com/ — X-ZELL is proud to announce that the company’s ground-breaking Next-Generation Cytology (NGC)... Read More →